433 related articles for article (PubMed ID: 28544305)
21. The biology of germ cell tumors in disorders of sex development.
Hersmus R; van Bever Y; Wolffenbuttel KP; Biermann K; Cools M; Looijenga LH
Clin Genet; 2017 Feb; 91(2):292-301. PubMed ID: 27716895
[TBL] [Abstract][Full Text] [Related]
22. Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology.
Looijenga LHJ; Kao CS; Idrees MT
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31658757
[TBL] [Abstract][Full Text] [Related]
23. Gonadoblastoma and selected other aspects of gonadal pathology in young patients with disorders of sex development.
Ulbright TM; Young RH
Semin Diagn Pathol; 2014 Sep; 31(5):427-40. PubMed ID: 25129544
[TBL] [Abstract][Full Text] [Related]
24. Etiological diagnosis of undervirilized male/XY disorder of sex development.
Atta I; Ibrahim M; Parkash A; Lone SW; Khan YN; Raza J
J Coll Physicians Surg Pak; 2014 Oct; 24(10):714-8. PubMed ID: 25327912
[TBL] [Abstract][Full Text] [Related]
25. Consensus guide on prophylactic gonadectomy in different sex development.
Guerrero-Fernández J; González-Peramato P; Rodríguez Estévez A; Alcázar Villar MJ; Audí Parera L; Azcona San Julián MC; Carcavilla Urquí A; Castaño González LA; Martos Tello JM; Mora Palma C; Moreno Macián MF; Yeste Fernández D; Nistal M
Endocrinol Diabetes Nutr (Engl Ed); 2022 Oct; 69(8):629-645. PubMed ID: 36369235
[TBL] [Abstract][Full Text] [Related]
26. The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients.
Slowikowska-Hilczer J; Szarras-Czapnik M; Wolski JK; Oszukowska E; Hilczer M; Jakubowski L; Walczak-Jedrzejowska R; Marchlewska K; Filipiak E; Kaluzewski B; Baka-Ostrowska M; Niedzielski J; Kula K
Folia Histochem Cytobiol; 2015; 53(3):218-26. PubMed ID: 26314751
[TBL] [Abstract][Full Text] [Related]
27. Sex chromosome DSD individuals with mosaic 45,X0 and aberrant Y chromosomes in 46,XY cells: distinct gender phenotypes and germ cell tumour risks
Vogt PH; Besikoglu B; Bettendorf M; Frank-Herrmann P; Zimmer J; Bender U; Knauer-Fischer S; Choukair D; Sinn P; Doerr HG; Woelfle J; Heidemann PH; Lau YC; Strowitzki T
Syst Biol Reprod Med; 2022 Aug; 68(4):247-257. PubMed ID: 35481403
[TBL] [Abstract][Full Text] [Related]
28. Gonadal malignancy in patients with differences of sex development.
Morin J; Peard L; Saltzman AF
Transl Androl Urol; 2020 Oct; 9(5):2408-2415. PubMed ID: 33209714
[TBL] [Abstract][Full Text] [Related]
29. Fertility in disorders of sex development: A review.
Van Batavia JP; Kolon TF
J Pediatr Urol; 2016 Dec; 12(6):418-425. PubMed ID: 27856173
[TBL] [Abstract][Full Text] [Related]
30. 46, XY disorder of sex development (DSD) complicated by a serous borderline tumor of the ovary: a case report and review of the literature.
Zhao J; Peng J; He S; Yang J; Pang X
Diagn Pathol; 2020 Jul; 15(1):93. PubMed ID: 32703224
[TBL] [Abstract][Full Text] [Related]
31. Frequency of gonadal tumours in complete androgen insensitivity syndrome (CAIS): A retrospective case-series analysis.
Chaudhry S; Tadokoro-Cuccaro R; Hannema SE; Acerini CL; Hughes IA
J Pediatr Urol; 2017 Oct; 13(5):498.e1-498.e6. PubMed ID: 28351649
[TBL] [Abstract][Full Text] [Related]
32. Is a CIS phenotype apparent in children with Disorders of Sex Development? Milder testicular dysgenesis is associated with a higher risk of malignancy.
Chemes HE; Venara M; Del Rey G; Arcari AJ; Musse MP; Papazian R; Forclaz V; Gottlieb S
Andrology; 2015 Jan; 3(1):59-69. PubMed ID: 25598272
[TBL] [Abstract][Full Text] [Related]
33. [Gonadal dysgenesis 46,XY DSD associated with variants in the MAP3K1 gene].
Kalinchenko NY; Tiulpakov AN
Probl Endokrinol (Mosk); 2020 Dec; 66(6):59-64. PubMed ID: 33481368
[TBL] [Abstract][Full Text] [Related]
34. Establishing reproductive potential and advances in fertility preservation techniques for XY individuals with differences in sex development.
Islam R; Lane S; Williams SA; Becker CM; Conway GS; Creighton SM
Clin Endocrinol (Oxf); 2019 Aug; 91(2):237-244. PubMed ID: 31004515
[TBL] [Abstract][Full Text] [Related]
35. Gonadal tumor development in 46,XX disorders of gonadal development.
Costanzo M; Touzon MS; Marino R; Guercio G; Ramirez P; Mattone MC; Pérez Garrido N; Bailez MM; Vaiani E; Ciaccio M; Galluzzo Mutti ML; Belgorosky A; Berensztein E
Eur J Endocrinol; 2022 Sep; 187(3):451-462. PubMed ID: 35900314
[TBL] [Abstract][Full Text] [Related]
36. Germ cell cancer risk in DSD patients.
Cools M
Ann Endocrinol (Paris); 2014 May; 75(2):67-71. PubMed ID: 24786700
[TBL] [Abstract][Full Text] [Related]
37. The current state of diagnostic genetics for conditions affecting sex development.
Alhomaidah D; McGowan R; Ahmed SF
Clin Genet; 2017 Feb; 91(2):157-162. PubMed ID: 28127758
[TBL] [Abstract][Full Text] [Related]
38. Differences of sex development in the newborn: from clinical scenario to molecular diagnosis.
Ibba A; Del Pistoia M; Balsamo A; Baronio F; Capalbo D; Russo G; DE Sanctis L; Bizzarri C
Minerva Pediatr (Torino); 2021 Dec; 73(6):606-620. PubMed ID: 34152117
[TBL] [Abstract][Full Text] [Related]
39. Delayed Recognition of Disorders of Sex Development (DSD): A Missed Opportunity for Early Diagnosis of Malignant Germ Cell Tumors.
Hersmus R; Stoop H; White SJ; Drop SL; Oosterhuis JW; Incrocci L; Wolffenbuttel KP; Looijenga LH
Int J Endocrinol; 2012; 2012():671209. PubMed ID: 22315593
[TBL] [Abstract][Full Text] [Related]
40. Emerging issues in disorders/differences of sex development (DSD).
Adam MP; Vilain E
Am J Med Genet C Semin Med Genet; 2017 Jun; 175(2):249-252. PubMed ID: 28577349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
